510(k) Report

510(k) · Cleared

Cleared

Elecsys Probnp Immunoassay

K022516510(k) TraditionalCleared Nov 19, 2002112-day reviewClass II21 CFR 862.1117

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · NBC Test, Natriuretic Peptide

Cleared on Nov 19, 2002 as substantially equivalent to DEN000010 (Biosite Incorporated, 2000) after a 112-day review. Its family tree reaches back 1 generation to 2000. 1 of the 48 devices in its family, counting itself, has a Class I recall. 46 later devices descend from it.

Decided
Nov 19, 2002
Review
112 days
Class
Class II
Product code
NBC
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN000010 (2000). 46 later devices descend from it, 9 citing it directly. 1 of the 48 devices in this family, counting this one, has a Class I recall.

Descendants, by year cleared 2008: 7 descendants cleared, 1 with a Class I recall12005: 3 descendants cleared2004: 2 descendants cleared2003: 1 descendant cleared2006: 5 descendants cleared2007: 2 descendants cleared2024: 1 descendant cleared2010: 2 descendants cleared2023: 3 descendants cleared2021: 2 descendants cleared2022: 2 descendants cleared2009: 1 descendant cleared2011: 2 descendants cleared2017: 1 descendant cleared2016: 1 descendant cleared2025: 1 descendant cleared2026: 3 descendants cleared2014: 1 descendant cleared2013: 1 descendant cleared2018: 2 descendants cleared2019: 3 descendants clearedDEN000010 · Triage B-Type Natriuretic Peptide (BNP) Test · Biosite Incorporated · 2000200020052010201520202025
Descendants, by generation 1 generation forward: 9 descendants2 generations forward: 13 descendants3 generations forward: 12 descendants, 1 with a Class I recall14 generations forward: 10 descendants5 generations forward: 1 descendant6 generations forward: 1 descendant DEN000010 · Triage B-Type Natriuretic Peptide (BNP) Test · Biosite Incorporated · 20000+5
  1. Root · 1 generation backDEN000010 Triage B-Type Natriuretic Peptide (BNP) TestBiosite Incorporated · 2000
  2. This deviceK022516 Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 2002
  3. Descendant · cites it directly · 44 of its ownK032646 Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 2003
  4. Descendant · cites it directly · 23 of its ownK051382 Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 2005
  5. Descendant · cites it directly · 20 of its ownK072437 Elecsys Probnp II, Precicontrol Cardiac II, Probnp II CalsetRoche Diagnostics · 2008
  6. Descendant · 2 generations on · 9 of its ownK082699 Elecsys Troponin I and Troponin I Stat Test SystemsRoche Diagnostics · 2009 · Recalled
  7. Descendant · 3 generations on · 8 of its ownK162895 Elecsys Troponin T Gen 5 STAT Assay, Elecsys Troponin T Gen 5 STAT…Roche Diagnostics · 2017

Showing 5 of 46 descendants. See all descendants

Descendants cleared per year

2003: 12004: 22005: 32006: 52007: 22008: 72009: 12010: 22011: 22013: 12014: 12016: 12017: 12018: 22019: 32021: 22022: 22023: 32024: 12025: 12026: 3
2003high 7 (2008) · low 0 (2012)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 46 · See all
  • K032646Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 2003 · cites it directly44descendants
  • K051382Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 2005 · cites it directly23descendants
  • K072437Elecsys Probnp II, Precicontrol Cardiac II, Probnp II CalsetRoche Diagnostics · 2008 · cites it directly20descendants
  • K082699Elecsys Troponin I and Troponin I Stat Test SystemsRoche Diagnostics · 2009 · 2 generations on9descendants
  • K162895Elecsys Troponin T Gen 5 STAT Assay, Elecsys Troponin T Gen 5 STAT CalSet, Elecsys…Roche Diagnostics · 2017 · 3 generations on8descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN000010Triage B-Type Natriuretic Peptide (BNP) TestBiosite Incorporated2000—
0 (this device)K022516Elecsys Probnp ImmunoassayRoche Diagnostics Corp.2002—
+1K032646Elecsys Probnp ImmunoassayRoche Diagnostics Corp.2003—
+1K051382Elecsys Probnp ImmunoassayRoche Diagnostics Corp.2005—
+1K072437Elecsys Probnp II, Precicontrol Cardiac II, Probnp II CalsetRoche Diagnostics2008—
+2K082699Elecsys Troponin I and Troponin I Stat Test SystemsRoche Diagnostics20094
+3K162895Elecsys Troponin T Gen 5 STAT Assay, Elecsys Troponin T Gen 5 STAT CalSet…Roche Diagnostics2017—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200420
200530
200650
200720
200871
200910
201020
201120
201310
201410
201610
201710
201820
201930
202120
202220
202330
202410
202510
202630
FIG. 1 — Lineage of K022516, 2000–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBC device

  1. #1 K262109 Access NT-proBNPscore 13.9 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN000010Triage B-Type Natriuretic Peptide (BNP) Test
Our reading of the summary gave K003475, which is not in FDA’s 510(k) list. The device the summary names is FDA’s De Novo DEN000010, Triage B-Type Natriuretic Peptide (BNP) Test (Biosite Incorporated), granted Nov 20, 2000; older De Novo requests were first filed under a 510(k) number, so this links to the grant.
Biosite Incorporated2000—

Also cleared against DEN000010: 1 other device →

What descends from it? (46)

See all 46

9 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K032646Elecsys Probnp ImmunoassayRoche Diagnostics Corp.200344
K051382Elecsys Probnp ImmunoassayRoche Diagnostics Corp.200523
K072437Elecsys Probnp II, Precicontrol Cardiac II, Probnp II CalsetRoche Diagnostics200820
K061795Dimension Vista PBNP Flex Reagent Cartridge and CalibratorDade Behring, Inc.20065
K043476Stratus CS Acute Care NT-Probnp Testpak, PBNP Calpak Calibrator, PBNP Dilpak DiluentDade Behring, Inc.20052
K042347Modification to Dimension NT-Probnp Flex Reagent Cartridge MethodDade Behring, Inc.20041
K041417Dimension NT-Probnp Flex Reagent Cartridge Method, Dimension PBNP Calibrator, Models…Dade Behring, Inc.20041
K063662Ramp NT-Probnp AssayResponse Biomedical Corp.20080
K073091Vidas NT-Probnp Assay, Model: 30 449bioMerieux, Inc.20080

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K080269Triage Cardioprofiler and Profiler S.O.B. PanelsBiosite Incorporated · 2008 · 3 generations on · ◆ in the 2008 descendants bar of FIG. 12 Class I recalls

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K032646 (Roche Diagnostics Corp., 2003) has gone furthest, with 44 descendants of its own.
  • 1 other device also cites its predicate DEN000010.

How does its category compare?

All NBC devices

NBC Test, Natriuretic Peptide: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NBC

1in 2025

2007: 22008: 72010: 12020: 12021: 22022: 12023: 22024: 12025: 12026 (partial year): 4
2007high 7 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBC

126in 2008

2008: 126 days median2026 (partial year): 94 days median
2007high 126 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBC

1in 2020

2010: 12012: 22014: 12015: 12018: 12020: 1
2007high 2 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NBC

17in 2025

2007: 172008: 152009: 352010: 612011: 532012: 232013: 132014: 702015: 432016: 312017: 92018: 72019: 92020: 62022: 42023: 262024: 142025: 17
2007high 70 (2014) · low 0 (2021)2025

MAUDE reports naming product code NBC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—017
20087126015
20090—035
20101—161
20110—053
20120—223
20130—013
20140—170
20150—143
20160—031
20170—09
20180—17
20190—09
20201—16
20212—00
20221—04
20232—026
20241—014
20251—017
20264940—

What is it indicated for?

Immunoassay for the in vitro quantitative determination of N-terminal pro-Brain natriuretic peptide in human serum and plasma. The Elecsys proBNP Immunoassay is intended for use as an aid in the diagnosis of individuals suspected of having congestive heart failure.

The electrochemiluminescence immunoassay "ECLIA" is intended for use on the Roche Elecsys family of analyzers.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K022516: Elecsys Probnp Immunoassay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K022516

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026